Anaplastic Large Cell Lymphoma

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) v::ALK Anaplastic Large Cell Lymphoma Crizotinib
Sensitivity (+) CD30 + Anaplastic Large Cell Lymphoma Brentuximab Vedotin, Cyclophosphamide, Doxorubicin, Prednisone
Sensitivity (+) CD30 + Anaplastic Large Cell Lymphoma Brentuximab Vedotin
Sensitivity (+) v::ALK Anaplastic Large Cell Lymphoma Crizotinib